OrthoEvra birth control patch
Recently there has been media reports about concerns for women using the OrthoEvra birth control patch. These reports have centered around the possibility of serious side effects such as blood clots, heart attacks and stroke. The reason for these reports is that patch users have been found to be exposed to 60% more estrogen than users of birth control pills. Women on birth control pills, however, do have peak blood concentrations of estrogen that are 25% higher than women on the patch. These differences occur because the patch results in a steady level of estrogen, while the pill results in daily peaks and troughs of estrogen.

What isn’t clear is if these blood level differences have any clinical significance for women. Serious side effects are very rare with hormonal birth control. Blood clots occur in approximately 5 per 100,000 women per year not using birth control versus about 15-30 per 100,000 women per year who are using hormonal birth control. Recent studies on the patch have given conflicting results. One has shown no increased risk in blood clots, heart attacks or stroke. The other has shown no increased risk for heart attack or stroke but has suggested a two-fold increase for blood clots. It is important to remember, however, that double a low risk is still a low risk. It’s also important to remember that pregnancy, which the patch is trying to prevent, has a risk of 60 per 100,000 women per year for blood clots.

At this point no there have been no new specific recommendations on the use of the patch by the FDA. Again, the risk of serious side effects is low. This risk, however, is increased if you smoke cigarettes and may be increased if you are obese or have a family history of blood clots or cardiovascular disease. The increased risk, though, would be true for any form of hormonal contraception not just the patch. The bottom line is that women should not panic and stop using the patch. If you are using the patch and have concerns we urge you to come in and discuss them with us. (top)

Comprehensive Healthcare for Women, PA
Launches Sophrona Sage Portal™


St. Paul, MN. (September 25, 2006) – Two months after implementation of Sophrona Solutions’ Sage Portal™ as its online patient communication system, Comprehensive Healthcare for Women, PA is realizing the increased clinical efficiency and patient convenience it had sought says Kay Olson, Office Manager. “Our doctors are able to see new patients faster because this technology has improved the flow of paperwork in our office.”

Within two weeks of launch, the HIPAA secure patient portal was handling 50% of Comprehensive Healthcare for Women, PA’s new patient registrations online. New patients now routinely register online to provide their full medical history, demographic, and insurance information at all hours of the day – when it’s convenient for them. They no longer come to the office early to fill out paperwork for their first appointment. Instead, when they arrive, they sign a form, sit down and are promptly shown to an examination room.

“We can now basically treat our new patients as existing patients when they arrive. The flow is much more smooth and efficient, “said Sam Arnold, MD, the president of the group. “There is nothing worse than having a new patient arrive for a 9am appointment and then be roomed at 9:25am. I’m just starting out my day and am already 25 minutes behind.”

Comprehensive Healthcare for Women, PA wanted to give its patients a way of conveniently scheduling appointments, paying bills, and filling out new patient registration without phone hassles and after hours. At the same time, the online patient communication solution needed to provide office staff with an easy to use, intuitive, and secure way of viewing and responding to patient communication. “We wanted the ability to view and respond to patient communication quickly and easily,” said Olson. “Sophrona clearly delivered this in its software. The office portal component of this solution is obviously designed for usability. Learning how to use it took less than 15 minutes.”

________________________________________________________
About Comprehensive Healthcare for Women, PA

Comprehensive Healthcare for Women, P.A. is committed to providing a more personal approach to medical care specifically for women. From its office in the southeast suburbs of St. Paul, its four board-certified health professionals offer comprehensive health care services for women in obstetrical and gynecological medicine and are supported by a full range of services including clinical labs and ultra sounds. For more information, visit www.chcw.net.

About Sophrona Solutions, Inc.

Sophrona Solutions Inc. is an innovative healthcare software technology firm which offers secure patient portal communication systems and patient adoption and marketing expertise to OB-GYN practices and clinics. Sophrona’s Sage Portal improves clinic efficiency and reduces phone call volume while helping grow patient volume and increasing patient retention. For more information, visit www.sophrona.com. (top)

The HPV Vaccine


One of the most dreaded phone calls a woman can get from her physician’s office is the one saying “we need you to come back in because your pap smear was abnormal.” Well now there is a new vaccine available that may significantly decrease the number of these phone calls in the future.

A pap smear is a screening test for precancerous changes on the cervix as well as cervical cancer. Abnormal pap smears are caused by human papilloma virus (HPV), a common asymptomatic sexually transmitted infection. There are over 100 types of HPV and as many as 50% of sexually active people will be exposed to or will have an HPV infection during their lifetime which is why abnormal pap smears occur so frequently. Most abnormalities are caused by HPV types 6, 11, 16, and 18. The first two cause 90% of genital warts and the latter two 70% of cervical cancers. The new HPV vaccine protects against these four types. So while the vaccine does not provide complete protection, it should significantly decrease a woman’s risk.

Most exposure to HPV occurs at younger ages so the FDA has approved the vaccine for ages 9-26. It is given as a series of three injections. The second and third are given two and six months after the first. Whether or not the vaccine is covered by insurance generally depends on whether or not your plan covers immunizations.

There are some important things to remember about this vaccine:

- It helps prevent genital warts and cervical cancer and pre-cancers
but it doesn’t treat them
- The vaccine doesn’t replace the need for regular pap smears
- The vaccine doesn’t protect against HPV types other than 6, 11, 16 and 18
- The vaccine doesn’t protect against HPV types if there has already been exposure
- The vaccine works best before a woman has contact with these HPV types
- Not everyone who gets the vaccine will be fully protected

So far there is data showing lasting immunity for five years after vaccination. Ongoing data will be collected to see if eventually a booster will be needed. Even if an individual already has HPV the vaccine can still be beneficial as it is unlikely that someone would be infected with all four types.

Here at Comprehensive Health Care For Women we do have the vaccine for those who are interested. If you would like to have your daughter vaccinated, but her clinic is not stocking the vaccine, we are happy to provide it for her as well. (top)

© 2008, Comprehensive Healthcare for Women, PA .